NKF-FDA workshop reviews endpoints for studies of chronic kidney disease. PDF Print
NKF: After extensive analysis of data from observational cohorts and interventional trials, the workshop planning committee and attendees recommended a 30 or 40% decline in glomerular filtration rate (GFR) as new surrogate endpoints for some clinical trials in chronic kidney disease used for regulatory approval.

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.